FACE TO FACE: Dr Kanury V S Rao, Co-Founder & CSO, PredOmix

In a highly informative conversation, Dr Kanury V S Rao, Co-Founder & Chief Scientific Officer, PredOmix spoke to Rahul Koul, Chief Editor, BioVoice News on how the combination of AI, big data and other digital tools help accelerate cancer research. The innovation-driven company based in Gurugram, Haryana is leveraging the power of artificial intelligence to develop new technologies in the fields of preventive healthcare and early-stage disease diagnosis.

Key Questions

♦ How is PredOmix enabling preventive healthcare to be more powerful through use of new age technologies such as Artificial Intelligence?

♦ What makes your product OncoVeryx so unique? Expectations and response so far?

♦ Is early-stage disease diagnosis through digital technologies really possible? How is the company enabling it?

♦ Which are the major areas of innovation that you intend to keep focusing on and why? Ongoing R&D projects being spearheaded by the company?

♦ Other products in the pipeline, key features & expected launch?

♦ Any partnerships with national and international organizations in academia and industry? What is the nature of such collaboration?

♦ Biotech startup ecosystem in India and the story so far?

♦ Where do you see the company in the next 5 years?

About Dr Kanury V S Rao, Co-Founder & Chief Scientific Officer, PredOmix

With over 3 decades of experience in the field of drug discovery and development, Dr. Kanury V S Rao has earlier served as Senior Scientist and Head of Immunology Group of the ICGEB, New Delhi for over 25 years. He was also instrumental in establishing the Drug Discovery Research Centre at THSTI, Faridabad between 2015 to 2017. Dr Rao is a recipient of several prestigious awards such as Shanti Swarup Bhatnagar Award, Millennium Medal, Ranbaxy Research Award among others.

Click here now to watch the full interview for detailed insights.